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SUMMARY 
Objective: There are many hearing impaired individuals in Monte Santo, a rural municipality 
in the state of Bahia, Brazil, including multiple familial cases strongly suggestive of a genetic 
aetiology.   
Methods: The present study investigated 81 subjects with hearing impairment (HI) recruited 
from 36 families.  Mutations previously associated with HI were initially analyzed: c.35delG 
in gene GJB2, del(GJB6-D13S1830) and del(GJB6-D13S1854) in gene GJB6, and A1555G 
in the mitochondrial gene MTRNR1, with additional mutations in GJB2 identified by 
sequencing the coding region of the gene. 
Results: Seven different mutations were present in GJB2 with mutations c.35delG and 
p.R75Q, which are known to be pathogenic, identified in 37.0% of the subjects.  Individuals 
homozygous for the c.35delG mutation were diagnosed in eight families, corresponding to 
24.6% of unrelated individuals with nonsyndromic hearing impairment (NSHI), and an 
additional heterozygote for this mutation was present in a single family.  Ten individuals 
(12.4%) in another family were heterozygous for the mutation p.R75Q. 
Conclusions: Significant heterogeneity was observed in the alleles and patterns of NSHI 
inheritance among the subjects studied, probably due to the extensive inter-ethnic admixture 
that characterizes the peoples of Brazil, and a high prevalence of community endogamy and 
consanguineous marriage. 
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INTRODUCTION 
Hearing impairment (HI) can result from genetic and/or environmental factors.  In 
developed countries approximately 60% of cases are hereditary, while 30% are acquired and 
10% have an undefined aetiology [1,2].  Of the hereditary forms of HI, nonsyndromic and 
syndromic disorders account for an estimated 70% and 30% of cases respectively [3,4].  
Although no nationally representative data are available on the prevalence or aetiology of HI 
in Brazil, most causes appear to be environmental in nature [5,6].  Several studies 
investigating the genetic basis of HI have, however, demonstrated the presence of a range of 
mostly recessive mutations [7-11]. 
Hereditary HI is highly heterogeneous, and to date mutations associated with 
nonsyndromic hearing impairment (NSHI) have been described in 63 genes exhibiting 
different modes of inheritance [12,13].  Despite the large numbers of genes and mutations 
implicated locus 13q11-q12 appears to be principally involved [14-17], with the genes GJB2 
and GJB6 present at this locus encoding the proteins connexin 26 (Cx26) and connexin 30 
(Cx30) [18-20].  Some 111 mutations associated with NSHI have been described in GJB2, of 
which 92 have an autosomal recessive (AR) mode of inheritance, nine are inherited as 
autosomal dominant (AD) mutations, and 10 others have no clearly defined pattern of 
transmission [17].  The most common AR mutation in patients with NSHI is c.35delG [21]. 
A high frequency of c.35delG mutation carriers has been reported in many European 
countries [21].  In São Paulo, Brazil this mutation was detected in 2.2% of 223 newborns 
studied [22], while another screening programme on 620 newborns also conducted in São 
Paulo indicated a carrier frequency for the mutation of 1.0% [23].  No previous molecular 
studies in individuals with HI have been conducted in northeastern Brazil, although the 
c.35delG mutation was identified in individuals of African ancestry with normal hearing 
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ability in Salvador, the state capital of Bahia, where the overall carrier frequency of the 
mutation was estimated to be 1.0% [24]. 
The 309 bp deletion del(GJB6-D13S1830) leads to a partial loss of GJB6.  This 
deletion was the second most frequent connexin mutation reported for NSHI in Spain, 
France, Israel, Great Britain and Brazil [20,25].  Individuals who are either homozygous for 
del(GJB6-D13S1830) or compound heterozygotes of del(GJB6-D13S1830) and a mutant 
allele of GJB2 develop NSHI, resulting in profound to severe HI [26].  The 232bp deletion 
del(GJB6-D13S1854) also leads to partial loss of GJB6 and has frequently been described in 
individuals with NSHI in Italy, England and Brazil [27]. 
Mutations in mitochondrial DNA have been associated with both syndromic and 
nonsyndromic HI [13,28]. The A1555G mutation in mitochondrial gene MTRNR1 has been 
identified in hereditary NSHI and in aminoglycoside-induced HI in families from several 
countries [29-33].  The A1555G mutation also has been reported in cases of NSHI in Brazil 
[8,9,34]. 
Due to widespread inter-ethnic admixture between people of European, African and 
Amerindian ancestry in the 500 years since European colonization, and more recent 
admixture with Middle Eastern and East Asian migrants, the Brazilian population has been 
described as one of the most heterogeneous in the world [35].  With a total population 
approaching 200 million, ethnicity in different regions of Brazil reflects both historical 
patterns of settlement and internal migration related to economic dynamics.  Within Bahia 
76.3% of residents, mainly living in the coastal regions, self-identified as being of African 
ancestry in the 2010 Census [36].  By comparison, an increasing proportion of European 
ancestry is seen in communities living in inland regions of the state [37]. 
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The aim of the present study was to investigate the genetic aetiology of HI by 
analyzing mutations in genes GJB2, GJB6 and MTRNR1 in individuals with hearing 
impairment from Monte Santo, a multi-ethnic inland community in Bahia. 
 
SUBJECTS AND METHODS 
Subjects 
According to the 2010 Census of Brazil the predominantly rural municipality of 
Monte Santo had a population of 52,338 inhabitants resident in some 200 villages [36].  
Eighty-one patients with HI recruited from 36 families resident in Monte Santo were 
investigated between 2008 and 2010.  The study initially included individuals with both 
sporadic and familial histories of HI, and with prelingual and postlingual HI.  However, 
individuals who presented with evidence of syndromic or postlingual HI but with no familial 
recurrence subsequently were excluded. 
Audiological evaluations using a tympanometry test, estimations of acoustic reflex 
thresholds (0.5, 1, 2 and 4 kHz), pure tone audiometry thresholds and evoked auditory 
brainstem response (ABR) were performed in the School of Audiology Clinic of the 
Metropolitan Union of Education and Culture College (UNIME), located in Lauro de Freitas, 
Bahia, Brazil. The study was approved by the Research Ethics Committee of the Gonçalo 
Moniz Research Center (CPqGM), Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia, 
Brazil (case no. 182/2008, protocol no. 274). Informed written consent was obtained from all 
individuals with HI, their legal representatives, or adult members of their immediate families. 
Molecular analysis 
Molecular analyses were performed at the Laboratory for Advanced Public Health at 
CPqGM/FIOCRUZ in Salvador, Bahia, Brazil.  Genomic DNA was extracted from peripheral 
blood leucocytes [38,39], with mutations in GJB2, the deletions del(GJB6-13S1830) and 
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del(GJB6-D13S1854) in GJB6, and the mitochondrial mutation A1555G in MTRNR1 
investigated.  All c.35delG/GJB2 mutations were first analyzed by PCR-RFLP using the 
BstNI enzyme [40,41].  The genotypes of all individuals with c.35delG mutations were 
confirmed by sequencing, and the mutations del(GJB6-D13S1830) and del(GJB6-D13S1854) 
were investigated by multiplex assays [27].  The A1555G/MTRNR1 mutation was 
investigated using a protocol described by Kupka et al. (2002) and analyses of the other 
mutations, including c.35delG, were performed by direct sequencing of the GJB2 coding 
region [43]. 
 
RESULTS 
Family backgrounds of the study population 
Preparatory genealogical investigations identified a total of 1,479 individuals 
belonging to 36 large extended families, 31 of which reported recurrence of HI.  Pedigree 
analysis indicated that 163 subjects with HI in the 36 extended families were of probable 
genetic origin, with 152 of these affected individuals resident in Monte Santo.  Of the 81 
people with HI recruited into the present study, 95.1% reported a family history of hearing 
defect.  No specific information on consanguinity was available for 11 subjects, but 36/70 
(52.2%) of the remaining cases were born to parents related as second cousins or closer 
(F≥0.0156). The average age of participants in the study was 32 years (range: 2–70 years), 
56.0% were male, 33.3% self-identified as White and 66.7% as Pardo (mixed ethnic 
ancestry). 
Audiological assessment 
In each of the study subjects the pattern of HI observed by imittance audiometry was 
suggestive of sensorineural HI, with all individuals presenting with bilateral HI and 94.0% 
reporting prelingual HI.  The average age at initial diagnosis of HI in the prelingual cases was 
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2.5 years (range: 1 month–12 years).  In the five reported cases of postlingual HI the average 
age of HI awareness or diagnosis was 17 years (range: 5–38 years).  Possible involvement of 
infectious diseases was reported in four postlingual cases: one with meningitis and three with 
measles.  However, both of these diseases were common in the overall study population with 
44.0% of all subjects reporting a history of measles, 1.5% with meningitis, and 1.5% with 
both diseases. 
Molecular analysis 
Seven mutations and 10 genotypes were identified by analysis of the coding region of 
GJB2 (Table 1).  As homozygous and heterozygous genotypes for the mutations c.35delG 
and p.R75Q are known to be pathogenic, a genetic aetiology for HI could therefore be 
confirmed in 30/81 (37.0%) of the subjects studied. 
Table 1 Summary of genotypes identified by analysis of the coding region 
of GJB2 in 81 individuals with HL from Monte Santo, Bahia, 
Brazil 
 
Genotype(s) Frequency (%) 
+/+ 47.1 
c.35delG/c.35delG** 24.7 
p.R75Q/+ ** 12.4 
c.-22-12C>T/+ 4.9 
c.-22-12C>T/p.V27I 1.2 
c.-15 C>T/+ 1.2 
c.35delG/+ 1.2 
p.V27I/+ 4.9 
p.K168R/+ 1.2 
c.*1C>T/+ 1.2 
 
+: wild-type allele; **genotypes known to be pathogenic 
Individuals homozygous for the mutation c.35delG were identified in eight families, 
corresponding to 14/57 (24.6%) of the individuals analyzed who were known to be non-
consanguineous or for whom information on consanguinity was unavailable.  Parental 
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consanguinity (F≥0.0156) was, however, reported in 11/20 (55.0%) of HI subjects with the 
c.35delG mutation.  A person heterozygous for c.35delG was found in one family, 
corresponding to 1.2% of patients with NSHI (Table 1).  Intra-familial genetic heterogeneity 
also was observed with, for example, a homozygous c35delG mutation identified in 
individual IV-13 (Fig. 2a), and individual IV-7 (Fig. 2b), but not in other persons with HI in 
their respective families. 
The p.R75Q mutation was responsible for NSHI in 12.4% of the cases analyzed.  All 
of these individuals were heterozygous for the p.R75Q mutation and they belonged to a 
single large non-consanguineous family.  Exceptionally, in this family HI segregated in a 
pattern typical of AD inheritance (Fig. 3).  Five other mutations in the coding region of gene 
GJB2 were identified in 12/81 (14.6%) of the individuals studied (Table 1).  Three of these 
mutations have been described as non-pathogenic polymorphisms: c.15C>T(-15C>T), 
p.V27I(p.Val27Ile or V27I) and c.*1C>T(682C>T) [17], and two were of undefined 
pathogenicity: c-22-12C>T(IVS1-12C>T) and p.K168R(K168R or p.Lys168Arg) [9,17,44]. 
 
 
DISCUSSION 
The 152 people diagnosed with NSHI represented 0.29% of the total population of the 
municipality, and so it has been estimated that at least 3/1,000 individuals living in the region 
have hereditary HI.  HI therefore appears to be more common in Monte Santo than elsewhere 
in the state of Bahia or in Brazil, where the prevalence of people with hearing defects has 
been estimated to be 1.7/1,000 and 1.8/1,000 respectively [36]. 
Mutations in the DFBN1 locus where GJB2 and GBJ6 are located have been 
implicated as one of the leading causes of hereditary HI, particularly in prelingual cases with 
an AR mode of inheritance [14-17,45].  In the present study, 94.0% of the cases were 
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reported as prelingual, yet neither deletion del(GJB6-D13S1830) nor del(GJB6-D13S1854) 
involving a partial loss of GJB6 was present in subjects from Monte Santo. 
Although there was no evidence to suggest maternal inheritance of HI in the families 
studied, the mitochondrial A1555G mutation in MTRNR1 was specifically investigated 
because of its prior identification in other Brazilian studies, including individuals with no 
indication of familial recurrence [7].  The mutation was also reported in Brazilians with 
profound HI who had been treated with aminoglycosides [7,8].  No subjects in the present 
study reported prior treatment with aminoglycosides, and contrary to previous Brazilian 
studies the A1555G mutation was not detected in any cases of HI from Monte Santo. 
Investigations into the genetic aetiology of HI have mainly focused on unrelated 
individuals [8,9,44,46-53].  The data in the present study are derived from a comprehensive 
community-based medical genetics survey established as a service for the inhabitants of the 
study region, with related individuals therefore included.  The genotypic frequency of 
mutation c.35delG was calculated both for all individuals and on the basis of a single affected 
individual per nuclear family.  Across all subjects with genotypically confirmed NSHI the 
frequency of homozygotes was 24.6% and 1.2% for heterozygotes, while for unrelated 
individuals only the corresponding frequencies were 24.1% for homozygotes and 1.7% for 
heterozygotes.  Equal numbers of c.35delG homozygous individuals self-identified as White 
or as Pardo. 
As shown in Table 2, the homozygote frequency for c.35delG in Monte Santo 
(24.1%) was significantly higher than reported elsewhere in Brazil, where the corresponding 
frequencies were 3.7-7.3%, and in diverse world populations with homozygote frequencies 
ranging from 0-18.0%.  However, it was lower than in Croatia [49], Italy [46], and Bulgaria 
[54], where 25.4%, 30.2% and 39.2% respectively of affected individuals were homozygous 
for the c.35delG mutation. 
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Table 2 Comparative frequencies of homozygotes for c.35delG in 
individuals with HL from Monte Santo, Brazil and other reference 
populations 
 
Location 
Frequency of 
mutant 
homozygotes (%) 
Reference 
Monte Santo, Brazil 24.1 Present study 
Espírito Santo, Brazil 3.9 Cordeiro-Silva et al. (2011) 
São Paulo, Brazil 7.3 Batissoco et al. (2009) 
Brazil (unstated) 6.5 Oliveira et al. (2007) 
   
Mexico 2.6 Arenas-Sordo et al. (2012) 
France 6.3 Roux et al. (2004) 
Italy (northern) 16.9 Primignani et al. (2009) 
Italy 30.2 Murgia et al. (1999) 
Croatia 25.4 Medica et al. (2005) 
Bulgaria (Bulgarian and Turkish) 39.2 Popova et al. (2012) 
Altai Republic (all Russian) 9.2 Posukh et al. (2005) 
Turkey 5.3 Baysal et al. (2008) 
Iran (Azerbaijani) 15.3 Bonyadi et al. (2009) 
Iran (Ardabil) 18.0 Davarnia et al. (2012) 
Iran (not stated) 10.0 Bazazzadegan et al. (2012) 
China (Han) 0.8 Xiao and Xie (2004) 
China (Han and other ethnicities)**  0.1 Dai et al. (2009) 
Saudi Arabia 6.4 Al-Qahtani et al. (2010) 
South Africa (Limpopo) 0.0 Kabahuma et al. (2011) 
 
**Han Chinese (n=1,640), Tibetan (n=122), Southwest region (n=119), Hui (n=79), Xinjiang 
(n=62), Mongolian (n=21), Maan (n=18) and Korean (n=2) 
 
In part, the variation in global genotype frequencies of c.35delG may be explained by 
founder effect 55], with evidence of a common founder mutation originating in Europe or the 
Middle East responsible for the high frequency of the c.35delG/GJB2 allele in Caucasians 
[21].  A population-based study reported high carrier frequencies of c.35delG allele in 
southern European countries, e.g. Portugal (1/45), Italy (1/40) and Spain (1/32) [21].  As the 
c.35delG homozygous individuals in Monte Santo self-identified either as White or Pardo 
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(mixed ancestry including White), it seems probable that the c.35delG mutation in the region 
was originally introduced during the successive waves of colonization from southern Europe 
that commenced in the early 16
th
 century. 
The high frequency of homozygotes for the c.35delG mutation in Monte Santo can be 
ascribed to small effective population sizes and drift, and to parental consanguinity which 
was identified in 52.2% of the subjects analyzed, and was present in 55.0% of individuals 
with HI caused by the c.35delG mutation.  However, as previously observed in a 
consanguineous Brazilian family [56], genetic heterogeneity was observed in familial cases 
of HI with an AR mode of inheritance, with the c.35delG mutation present in only some 
affected subjects (Figs. 2a, 2b).  Rather than being confined to a small number of specific 
families and to a restricted number of inherited disorders, the phenomenon of disease 
heterogeneity within closely related families has been increasingly reported across a variety 
of recessive disorders [57]. 
The p.R75Q (OMIM, img 121011.0026) mutation has variously been described in 
subjects with HI in Turkey [58], France [59], a family of Russian origin [60], and in 1/207 
patients in Brazil [8].  In these cases an AD mode of inheritance was observed, and in some 
subjects the HI was associated with palmoplantar keratoderma [58, 59].  An AD mode of 
inheritance appeared probable in the present study in which 10 members of a family with no 
reported consanguinity had HI, three of whom also had palmoplantar keratoderma. 
As yet the pathogenicity of the p.K168R mutation remains to be resolved [8,9].  In 
São Paulo, Brazil, two of 300 individuals (0.7%) with NSHI were heterozygous for p.K168R.  
There were, however, no individuals with the mutation in an analysis of 100 Brazilians, 50 
each of European and African ancestry, and investigation of the mutation phenotype 
concluded that it probably was a non-pathogenic variant [9].  In Monte Santo the p.K168R 
mutation was present in a single individual who reported a family history of NSHI, so further 
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studies comparing individuals with and without HI in this family could contribute to 
clarification of the phenotype. 
Given the extensive family histories of NSHI (95.1%) in Monte Santo, it appears 
highly probable that many other cases of HI which are still to be investigated are genetic in 
origin, with complementary studies therefore merited to identify the causative mutations and 
characterize the disease phenotypes.  Similarities in their history of colonization and in the 
resultant ethnic profiles of other northeastern states of Brazil suggest that the mutations found 
in Bahia also will be important causes of hereditary HI in the populations of neighbouring 
states.  By comparison, with the exception of the apparent high prevalence of GJB2 mutations 
throughout Brazil, it seems likely that the mutation profiles of HI in other regions of the 
country will be population-specific and reflect their particular demographic and genetic 
histories, and marital practices. 
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Legends to figures 
 
Fig. 1 Family pedigree with inherited HI caused by a c.35delG mutation in homozygous 
individuals.  The three subjects recruited into the study are indicated by an asterisk. 
 
 
 
 
Fig. 2 Illustrative pedigrees of two families with HI, an AR pattern of inheritance (Fig. 2a), 
and a heterogeneous aetiology of hearing impairment (Fig. 2b).  The four subjects in each 
family recruited into the study are indicated by asterisks.  HI was caused by a homozygous 
c.35delG mutation in individual IV-13, Fig. 2(a) and individual IV–7, Fig. 2(b).  Information 
on other individuals with HI in this family but not included in the study was provided by 
relatives.  Subjects who reported presbycusis (age-related HI) are indicated by hatched 
shading. 
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Fig. 3 Family pedigree with HI suggestive of an AD mode of inheritance, caused by a 
p.R75Q mutation in heterozygous individuals.  The 10 subjects recruited into the study are 
indicated by asterisks; the three subjects with HI and palmoplantar keratoderma are circled.  
Information on other individuals with HL in this family but not included in the study was 
provided by relatives. 
 
 
 
 
